Zhang C.et al. confirmed that non-Mitogenic aFGF could prevent diabetic cardiomyopathy from cardiac oxidative stress damage, cardiomyocyte hypertrophy and myocardial fibrosis (Zhang et al., 2013). This evidence concerns the gene FGF1 and diabetic cardiomyopathy.